Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOLVAPTAN Cause Chronic kidney disease? 52 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Chronic kidney disease have been filed in association with TOLVAPTAN (Jynarque). This represents 0.6% of all adverse event reports for TOLVAPTAN.

52
Reports of Chronic kidney disease with TOLVAPTAN
0.6%
of all TOLVAPTAN reports
12
Deaths
26
Hospitalizations

How Dangerous Is Chronic kidney disease From TOLVAPTAN?

Of the 52 reports, 12 (23.1%) resulted in death, 26 (50.0%) required hospitalization, and 1 (1.9%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does TOLVAPTAN Cause?

Death (800) Thirst (624) Off label use (560) Renal impairment (534) Underdose (448) Product use in unapproved indication (446) Wrong technique in product usage process (426) Polyuria (390) Product dose omission issue (379) Inappropriate schedule of product administration (376)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which TOLVAPTAN Alternatives Have Lower Chronic kidney disease Risk?

TOLVAPTAN vs TOPAMAX TOLVAPTAN vs TOPIRAMATE TOLVAPTAN vs TOPOTECAN TOLVAPTAN vs TOPOTECAN\TOPOTECAN TOLVAPTAN vs TOPROL

Related Pages

TOLVAPTAN Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease TOLVAPTAN Demographics